REPLIGEN CORP — Director's Dealing 2019

Mar 20, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2019-03-18

Reporting Person: Hunt Anthony (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-18	Common Stock	S	10041	$59.2384	Disposed	219616	Direct
2019-03-18	Common Stock	S	4009	$60.4547	Disposed	215607	Direct
2019-03-18	Common Stock	S	500	$60.914	Disposed	215107	Direct

Footnotes

F1: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 21, 2018.

F2: $59.2384 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.87 to $59.835, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: $60.4547 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.87 to $60.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4: $60.9140 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.89 to $60.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.